DIA
Drug Information Association Logo
« Back to Listing

Nanotechnology: Application to Medical Products

Track:
Nonclinical and Translational Development/Early Phase Clinical Development

Day & Time:
June 17, 8:00AM - 9:30AM (Pacific Standard Time)

Session Number:
207

Room Number:
7B

Level:
Basic

Type:
Session

Title:
Nanotechnology: Application to Medical Products

Chair(s):
Suzanne Sensabaugh
President and Principle Consultant
Hartmannwillner LLC, United States

Description:
This session will address the topic of nanotechnology with a focus on its use for drugs and biologics. It will define the term; provide a basic overview of the technology and uses; and address development, scientific, and regulatory challenges.

Learning Objective(s):
Define nanotechnology; Explain the application of nanotechnology as it relates to drugs and biologics; Describe the current landscape of medical products in development; Enumerate development, scientific, and regulatory challenges; Identify the preclinical and clinical requirements.

Presentation(s) & Speaker(s):
Biomedical Nanotechnology: The Smaller the Thing, the Bigger the Challenge
Michael Drues, PhD
Founder and President
Vascular Sciences, United States

Nanomaterials in Drug Products: A Regulatory Update
Celia N. Cruz, PhD
Senior Product Quality Reviewer, OPS, CDER
FDA, United States

Industry Perspectives of Nanomedicines: It's a Small World After All
Frank J Malinoski, MD, PhD
Chief Medical Officer
Liquidia Technologies, United States